ArticleTranslational pediatrics2025
Efficacy of bronchoalveolar lavage in treating mycoplasma pneumonia and bacterial pneumonia with atelectasis in children.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A2063G macrolide-resistant Mycoplasma pneumoniae: epidemic dominance without more frequent pulmonary consolidation or worse short-term in-hospital outcomes in hospitalized children.BMC pediatrics · 2026Article
- A prediction model for bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and consolidation.Scientific reports · 2026Article
- Prediction of atelectasis inFrontiers in pediatrics · 2026Article
- Analysis of risk factors for otitis media in hospitalized children aged ≤ 12 years with bacterial pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary atelectasis (PA) is a severe complication of pneumonia in children. Despite the growing use of fiberoptic bronchoscopy, the effectiveness of bronchoalveolar lavage (BAL) in treating PA caused by various pathogens remains uncertain. This study aims to evaluate the efficacy of BAL in PA associated with different pathogens and to identify factors influencing treatment outcomes. Methods: We conducted a retrospective analysis on 185 children with PA between 2017-2021. Clinical data were collected and compared between different groups using a propensity score-matching analysis. Results: A total of 185 patients were included in the study, divided into two groups based on whether BAL was performed (BAL group, n=146; non-BAL group, n=39). The patients in the BAL group had a longer fever duration, a higher proportion of neutrophils, elevated lactate dehydrogenase (LDH) levels, and a longer duration of antibiotic use prior to admission (all P<0.05). After applying propensity score matching (PSM), 35 cases were enrolled in each group. We further stratified the patients based on the pathogens identified. Furthermore, we found that patients in the Conclusions: BAL could increase the incidence of lung recruitment and shorten the CRP recovery time in MPP patients with PA, but it could not make any improvement in PA patients caused by the bacterium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.